+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
lohexol API Market - Global Forecast 2026-2032- Product Image
lohexol API Market - Global Forecast 2026-2032- Product Image
Sale

lohexol API Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6148847
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The lohexol API Market is projected to reach USD 739.38 Million in 2026. It is expected to continue growing at a CAGR of 5.71%, reaching USD 1.03 Billion by 2032.

Lohexol API: Executive Overview

Lohexol is a nonionic, low-osmolar iodinated contrast medium active pharmaceutical ingredient used in the manufacture of injectable products for diagnostic imaging. Its relevance is linked to continued demand for computed tomography, angiography, and urography, as well as the need for consistent pharmaceutical quality, regulatory compliance, and dependable supply of critical inputs.

Supply Resilience and Quality Are Reshaping the Lohexol API Landscape

The lohexol API landscape is being shaped by tighter expectations for traceability, impurity control, validated manufacturing processes, and continuity of supply. Buyers increasingly evaluate suppliers on documentation quality, batch consistency, change-control discipline, regulatory support, and the ability to manage disruptions affecting iodine-containing materials, specialized equipment, utilities, and international logistics. Environmental controls and responsible waste management are also becoming more relevant as manufacturers seek to reduce the operational footprint of pharmaceutical production.

Artificial Intelligence Is Strengthening Quality and Supply Decisions

Artificial intelligence can support lohexol API operations by identifying process deviations, improving analytical data review, and helping manufacturers detect relationships among raw-material attributes, process conditions, and final-product quality. Machine-learning tools may also improve maintenance planning, inventory visibility, demand sensing, and investigation workflows. These benefits depend on validated models, representative data, cybersecurity controls, human oversight, and compliance with applicable pharmaceutical quality requirements; AI should therefore augment, rather than replace, expert process and quality judgment.

Regional Insights: Regulatory Maturity and Imaging Access Drive Priorities

North America emphasizes stringent quality systems, reliable sourcing, and regulatory documentation, while Latin America places added importance on import continuity, local registration requirements, and dependable distribution. Europe combines strong expectations for pharmaceutical manufacturing controls with supply-chain resilience and environmental scrutiny. The Middle East is influenced by healthcare infrastructure investment, procurement coordination, and reliance on qualified external suppliers. Africa’s priorities vary with diagnostic access, public-health procurement, logistics reliability, and technical support. Asia-Pacific remains important for pharmaceutical manufacturing capabilities, imaging demand, regulatory modernization, and the integration of regional and international supply networks.

Group Insights: Trade Networks and Regulatory Alignment Shape Access

ASEAN markets are influenced by regional trade integration, differing registration pathways, and the need for dependable cross-border supply. BRICS members reflect diverse manufacturing strengths, healthcare systems, and regulatory environments, making documentation portability and local compliance important. The European Union benefits from harmonized regulatory principles while maintaining rigorous expectations for quality and environmental performance. G7 economies generally prioritize advanced quality oversight, supply assurance, and technology-enabled manufacturing. GCC countries emphasize coordinated procurement, healthcare capacity expansion, and qualified international supply. NATO members may place additional value on strategic resilience, continuity planning, and secure access to essential healthcare inputs.

Country Insights: Diverse Regulatory and Manufacturing Conditions

Australia prioritizes stringent therapeutic regulation and dependable imported supply. Brazil combines a substantial healthcare system with detailed local compliance and distribution requirements. Canada emphasizes quality documentation, regulatory alignment, and resilient access across a geographically broad market. China has expanding pharmaceutical capabilities alongside evolving regulatory expectations and domestic supply-chain priorities. France, Germany, Italy, and Spain operate within the European Union framework while maintaining strong national healthcare and quality-control practices. India combines pharmaceutical manufacturing depth with growing attention to process validation and regulatory compliance. Japan and South Korea emphasize high manufacturing standards, analytical rigor, and advanced healthcare infrastructure. Mexico is influenced by regional trade links, import procedures, and expanding diagnostic capacity. Russia presents a distinct regulatory and logistics environment requiring careful assessment of sourcing and market-access conditions. The United Kingdom maintains demanding quality and regulatory expectations alongside a distinct post-EU operating framework. The United States emphasizes stringent regulatory controls, supplier qualification, traceability, and continuity of critical pharmaceutical inputs.

Actions for Leaders: Build Qualified, Transparent, and Adaptive Supply

Industry leaders should diversify qualified sources without weakening quality oversight; maintain robust supplier audits, technical agreements, and change-notification procedures; and map dependencies for iodine-related materials, specialized manufacturing steps, and transportation routes. They should strengthen analytical capabilities for impurity and residual control, invest in validated digital and AI tools, and establish clear human review of automated outputs. Regulatory teams should maintain market-specific dossiers and readiness for inspections, while procurement and operations teams should use risk-based inventory policies, scenario planning, and documented business-continuity procedures. Sustainability initiatives should address energy, water, waste, and solvent management without compromising product quality.

Research Methodology: Evidence-Based Interpretation of the API Ecosystem

This executive summary interprets the lohexol API landscape through established pharmaceutical, regulatory, manufacturing, healthcare, and supply-chain considerations. The assessment organizes implications across the required regions, economic and political groupings, and countries, focusing on verified structural factors such as quality expectations, diagnostic-imaging access, trade conditions, manufacturing capabilities, and regulatory environments. It intentionally excludes market estimates, market sizing, market shares, forecasts, and company-specific assessments. Conclusions should be validated against current regulatory notices, official trade and health data, pharmacopeial standards, procurement requirements, and supplier documentation before operational decisions are made.

Conclusion: Quality Assurance and Resilience Define Competitive Readiness

The lohexol API environment is defined less by a single demand driver than by the interaction of diagnostic-imaging needs, strict pharmaceutical quality requirements, regulatory variation, and supply-chain exposure. Organizations that combine validated manufacturing, transparent documentation, diversified sourcing, disciplined change control, and carefully governed digital tools will be better positioned to support reliable contrast-product production. Regional and country-specific compliance planning remains essential because operational priorities differ across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. lohexol API Market, by Product Form
7.1. Introduction
7.2. Injection Solution
7.2.1. Concentrated
7.2.2. Ready To Use
7.3. Powder For Injection
7.4. Premixed Syringes
8. lohexol API Market, by Route Of Administration
8.1. Introduction
8.2. Intraarterial
8.3. Intrathecal
8.4. Intravenous
9. lohexol API Market, by End User
9.1. Introduction
9.2. Ambulatory Care Facilities
9.3. Diagnostic Imaging Centers
9.4. Hospitals
9.5. Research Laboratories
10. lohexol API Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
11. lohexol API Market, by Application
11.1. Introduction
11.2. Angiography
11.2.1. CT Angiography
11.2.2. Digital Subtraction Angiography
11.3. Computed Tomography
11.3.1. Contrast Enhanced CT
11.3.2. Non-Contrast CT
11.4. Myelography
11.5. Urography
12. lohexol API Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. lohexol API Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. lohexol API Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Alchem International Private Limited
16.2. Aurora Industry Co., Ltd.
16.3. Divi’s Laboratories Limited
16.4. GE HealthCare Technologies Inc.
16.5. Global Pharma Tek, LLC
16.6. Hovione Farmaciência SA
16.7. Imax Diagnostic Imaging Co., Ltd.
16.8. Interpharma Praha, a.s.
16.9. Jodas Expoim Private Limited
16.10. Justesa Imagen, S.A.
16.11. Lupin Limited
16.12. Manus Aktteva Biopharma LLP
16.13. Olon S.p.A.
16.14. Otsuka Chemical Co., Ltd.
16.15. Pfizer Inc.
16.16. Rochem International, Inc.
16.17. Shaoxing Hantai Pharmaceutical Co., Ltd.
16.18. Zhejiang Hisun Pharmaceutical Co., Ltd.
16.19. Zhejiang Neo-Dankong Pharmaceutical Co., Ltd.
16.20. Zhejiang Starry Pharmaceutical Co., Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global lohexol API Market, Years Considered for the Study
FIGURE 2. Global lohexol API Market, Research Design
FIGURE 3. Global lohexol API Market, Research Framework
FIGURE 4. Global lohexol API Market, Data Triangulation
FIGURE 5. Global lohexol API Market Size, 2017-2032 (USD Million)
FIGURE 6. Global lohexol API Market Size, by Product Form, 2025 vs 2032 (%)
FIGURE 7. Global lohexol API Market Size, by Product Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global lohexol API Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 9. Global lohexol API Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global lohexol API Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global lohexol API Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global lohexol API Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global lohexol API Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global lohexol API Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global lohexol API Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global lohexol API Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global lohexol API Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global lohexol API Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global lohexol API Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global lohexol API Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global lohexol API Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global lohexol API Market Segmentation & Coverage
TABLE 2. Global lohexol API Market Size, 2017-2032 (USD Million)
TABLE 3. Global lohexol API Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 4. Global Injection Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Injection Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Injection Solution Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Concentrated Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Concentrated Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Concentrated Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Ready To Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Ready To Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Ready To Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Powder For Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Powder For Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Powder For Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Premixed Syringes Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Premixed Syringes Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Premixed Syringes Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global lohexol API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 20. Global Intraarterial Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Intraarterial Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Intraarterial Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Intrathecal Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Intrathecal Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Intrathecal Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global lohexol API Market Size, by End User, 2017-2032 (USD Million)
TABLE 30. Global Ambulatory Care Facilities Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Ambulatory Care Facilities Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Ambulatory Care Facilities Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Diagnostic Imaging Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Diagnostic Imaging Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Diagnostic Imaging Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Research Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Research Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Research Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global lohexol API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 43. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global lohexol API Market Size, by Application, 2017-2032 (USD Million)
TABLE 53. Global Angiography Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Angiography Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Angiography Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global CT Angiography Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global CT Angiography Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global CT Angiography Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Digital Subtraction Angiography Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Digital Subtraction Angiography Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Digital Subtraction Angiography Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Computed Tomography Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Computed Tomography Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Computed Tomography Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Contrast Enhanced CT Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Contrast Enhanced CT Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Contrast Enhanced CT Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Non-Contrast CT Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Non-Contrast CT Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Non-Contrast CT Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Myelography Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Myelography Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Myelography Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Urography Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Urography Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Urography Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global lohexol API Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific lohexol API Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific lohexol API Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific lohexol API Market Size, by Injection Solution, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific lohexol API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific lohexol API Market Size, by End User, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific lohexol API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific lohexol API Market Size, by Application, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific lohexol API Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific lohexol API Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 87. North America lohexol API Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. North America lohexol API Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 89. North America lohexol API Market Size, by Injection Solution, 2017-2032 (USD Million)
TABLE 90. North America lohexol API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 91. North America lohexol API Market Size, by End User, 2017-2032 (USD Million)
TABLE 92. North America lohexol API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 93. North America lohexol API Market Size, by Application, 2017-2032 (USD Million)
TABLE 94. North America lohexol API Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 95. North America lohexol API Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 96. Latin America lohexol API Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Latin America lohexol API Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 98. Latin America lohexol API Market Size, by Injection Solution, 2017-2032 (USD Million)
TABLE 99. Latin America lohexol API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 100. Latin America lohexol API Market Size, by End User, 2017-2032 (USD Million)
TABLE 101. Latin America lohexol API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 102. Latin America lohexol API Market Size, by Application, 2017-2032 (USD Million)
TABLE 103. Latin America lohexol API Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 104. Latin America lohexol API Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 105. Europe lohexol API Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Europe lohexol API Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 107. Europe lohexol API Market Size, by Injection Solution, 2017-2032 (USD Million)
TABLE 108. Europe lohexol API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 109. Europe lohexol API Market Size, by End User, 2017-2032 (USD Million)
TABLE 110. Europe lohexol API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 111. Europe lohexol API Market Size, by Application, 2017-2032 (USD Million)
TABLE 112. Europe lohexol API Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 113. Europe lohexol API Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 114. Middle East lohexol API Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Middle East lohexol API Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 116. Middle East lohexol API Market Size, by Injection Solution, 2017-2032 (USD Million)
TABLE 117. Middle East lohexol API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 118. Middle East lohexol API Market Size, by End User, 2017-2032 (USD Million)
TABLE 119. Middle East lohexol API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 120. Middle East lohexol API Market Size, by Application, 2017-2032 (USD Million)
TABLE 121. Middle East lohexol API Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 122. Middle East lohexol API Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 123. Africa lohexol API Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Africa lohexol API Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 125. Africa lohexol API Market Size, by Injection Solution, 2017-2032 (USD Million)
TABLE 126. Africa lohexol API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 127. Africa lohexol API Market Size, by End User, 2017-2032 (USD Million)
TABLE 128. Africa lohexol API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 129. Africa lohexol API Market Size, by Application, 2017-2032 (USD Million)
TABLE 130. Africa lohexol API Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 131. Africa lohexol API Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 132. Global lohexol API Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. ASEAN lohexol API Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. ASEAN lohexol API Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 135. ASEAN lohexol API Market Size, by Injection Solution, 2017-2032 (USD Million)
TABLE 136. ASEAN lohexol API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 137. ASEAN lohexol API Market Size, by End User, 2017-2032 (USD Million)
TABLE 138. ASEAN lohexol API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 139. ASEAN lohexol API Market Size, by Application, 2017-2032 (USD Million)
TABLE 140. ASEAN lohexol API Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 141. ASEAN lohexol API Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 142. GCC lohexol API Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. GCC lohexol API Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 144. GCC lohexol API Market Size, by Injection Solution, 2017-2032 (USD Million)
TABLE 145. GCC lohexol API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 146. GCC lohexol API Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. GCC lohexol API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 148. GCC lohexol API Market Size, by Application, 2017-2032 (USD Million)
TABLE 149. GCC lohexol API Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 150. GCC lohexol API Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 151. European Union lohexol API Market Size, by Group, 2017-2032 (USD Million)
TABLE 152. European Union lohexol API Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 153. European Union lohexol API Market Size, by Injection Solution, 2017-2032 (USD Million)
TABLE 154. European Union lohexol API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 155. European Union lohexol API Market Size, by End User, 2017-2032 (USD Million)
TABLE 156. European Union lohexol API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 157. European Union lohexol API Market Size, by Application, 2017-2032 (USD Million)
TABLE 158. European Union lohexol API Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 159. European Union lohexol API Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 160. BRICS lohexol API Market Size, by Group, 2017-2032 (USD Million)
TABLE 161. BRICS lohexol API Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 162. BRICS lohexol API Market Size, by Injection Solution, 2017-2032 (USD Million)
TABLE 163. BRICS lohexol API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 164. BRICS lohexol API Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. BRICS lohexol API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 166. BRICS lohexol API Market Size, by Application, 2017-2032 (USD Million)
TABLE 167. BRICS lohexol API Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 168. BRICS lohexol API Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 169. G7 lohexol API Market Size, by Group, 2017-2032 (USD Million)
TABLE 170. G7 lohexol API Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 171. G7 lohexol API Market Size, by Injection Solution, 2017-2032 (USD Million)
TABLE 172. G7 lohexol API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 173. G7 lohexol API Market Size, by End User, 2017-2032 (USD Million)
TABLE 174. G7 lohexol API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 175. G7 lohexol API Market Size, by Application, 2017-2032 (USD Million)
TABLE 176. G7 lohexol API Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 177. G7 lohexol API Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 178. NATO lohexol API Market Size, by Group, 2017-2032 (USD Million)
TABLE 179. NATO lohexol API Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 180. NATO lohexol API Market Size, by Injection Solution, 2017-2032 (USD Million)
TABLE 181. NATO lohexol API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 182. NATO lohexol API Market Size, by End User, 2017-2032 (USD Million)
TABLE 183. NATO lohexol API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 184. NATO lohexol API Market Size, by Application, 2017-2032 (USD Million)
TABLE 185. NATO lohexol API Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 186. NATO lohexol API Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 187. Global lohexol API Market Size, by Country, 2017-2032 (USD Million)
TABLE 188. United States lohexol API Market Size, 2017-2032 (USD Million)
TABLE 189. United States lohexol API Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 190. United States lohexol API Market Size, by Injection Solution, 2017-2032 (USD Million)
TABLE 191. United States lohexol API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 192. United States lohexol API Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. United States lohexol API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 194. United States lohexol API Market Size, by Application, 2017-2032 (USD Million)
TABLE 195. United States lohexol API Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 196. United States lohexol API Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 197. Canada lohexol API Market Size, 2017-2032 (USD Million)
TABLE 198. Canada lohexol API Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 199. Canada lohexol API Market Size, by Injection Solution, 2017-2032 (USD Million)
TABLE 200. Canada lohexol API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 201. Canada lohexol API Market Size, by End User, 2017-2032 (USD Million)
TABLE 202. Canada lohexol API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 203. Canada lohexol API Market Size, by Application, 2017-2032 (USD Million)
TABLE 204. Canada lohexol API Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 205. Canada lohexol API Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 206. Mexico lohexol API Market Size, 2017-2032 (USD Million)
TABLE 207. Mexico lohexol API Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 208. Mexico lohexol API Market Size, by Injection Solution, 2017-2032 (USD Million)
TABLE 209. Mexico lohexol API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 210. Mexico lohexol API Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. Mexico lohexol API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 212. Mexico lohexol API Market Size, by Application, 2017-2032 (USD Million)
TABLE 213. Mexico lohexol API Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 214. Mexico lohexol API Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 215. Brazil lohexol API Market Size, 2017-2032 (USD Million)
TABLE 216. Brazil lohexol API Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 217. Brazil lohexol API Market Size, by Injection Solution, 2017-2032 (USD Million)
TABLE 218. Brazil lohexol API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 219. Brazil lohexol API Market Size, by End User, 2017-2032 (USD Million)
TABLE 220. Brazil lohexol API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 221. Brazil lohexol API Market Size, by Application, 2017-2032 (USD Million)
TABLE 222. Brazil lohexol API Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 223. Brazil lohexol API Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 224. United Kingdom lohexol API Market Size, 2017-2032 (USD Million)
TABLE 225. United Kingdom lohexol API Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 226. United Kingdom lohexol API Market Size, by Injection Solution, 2017-2032 (USD Million)
TABLE 227. United Kingdom lohexol API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 228. United Kingdom lohexol API Market Size, by End User, 2017-2032 (USD Million)
TABLE 229. United Kingdom lohexol API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 230. United Kingdom lohexol API Market Size, by Application, 2017-2032 (USD Million)
TABLE 231. United Kingdom lohexol API Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 232. United Kingdom lohexol API Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 233. Germany lohexol API Market Size, 2017-2032 (USD Million)
TABLE 234. Germany lohexol API Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 235. Germany lohexol API Market Size, by Injection Solution, 2017-2032 (USD Million)
TABLE 236. Germany lohexol API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 237. Germany lohexol API Market Size, by End User, 2017-2032 (USD Million)
TABLE 238. Germany lohexol API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 239. Germany lohexol API Market Size, by Application, 2017-2032 (USD Million)
TABLE 240. Germany lohexol API Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 241. Germany lohexol API Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 242. France lohexol API Market Size, 2017-2032 (USD Million)
TABLE 243. France lohexol API Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 244. France lohexol API Market Size, by Injection Solution, 2017-2032 (USD Million)
TABLE 245. France lohexol API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 246. France lohexol API Market Size, by End User, 2017-2032 (USD Million)
TABLE 247. France lohexol API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 248. France lohexol API Market Size, by Application, 2017-2032 (USD Million)
TABLE 249. France lohexol API Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 250. France lohexol API Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 251. Russia lohexol API Market Size, 2017-2032 (USD Million)
TABLE 252. Russia lohexol API Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 253. Russia lohexol API Market Size, by Injection Solution, 2017-2032 (USD Million)
TABLE 254. Russia lohexol API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 255. Russia lohexol API Market Size, by End User, 2017-2032 (USD Million)
TABLE 256. Russia lohexol API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 257. Russia lohexol API Market Size, by Application, 2017-2032 (USD Million)
TABLE 258. Russia lohexol API Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 259. Russia lohexol API Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 260. Italy lohexol API Market Size, 2017-2032 (USD Million)
TABLE 261. Italy lohexol API Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 262. Italy lohexol API Market Size, by Injection Solution, 2017-2032 (USD Million)
TABLE 263. Italy lohexol API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 264. Italy lohexol API Market Size, by End User, 2017-2032 (USD Million)
TABLE 265. Italy lohexol API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 266. Italy lohexol API Market Size, by Application, 2017-2032 (USD Million)
TABLE 267. Italy lohexol API Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 268. Italy lohexol API Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 269. Spain lohexol API Market Size, 2017-2032 (USD Million)
TABLE 270. Spain lohexol API Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 271. Spain lohexol API Market Size, by Injection Solution, 2017-2032 (USD Million)
TABLE 272. Spain lohexol API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 273. Spain lohexol API Market Size, by End User, 2017-2032 (USD Million)
TABLE 274. Spain lohexol API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 275. Spain lohexol API Market Size, by Application, 2017-2032 (USD Million)
TABLE 276. Spain lohexol API Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 277. Spain lohexol API Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 278. China lohexol API Market Size, 2017-2032 (USD Million)
TABLE 279. China lohexol API Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 280. China lohexol API Market Size, by Injection Solution, 2017-2032 (USD Million)
TABLE 281. China lohexol API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 282. China lohexol API Market Size, by End User, 2017-2032 (USD Million)
TABLE 283. China lohexol API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 284. China lohexol API Market Size, by Application, 2017-2032 (USD Million)
TABLE 285. China lohexol API Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 286. China lohexol API Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 287. India lohexol API Market Size, 2017-2032 (USD Million)
TABLE 288. India lohexol API Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 289. India lohexol API Market Size, by Injection Solution, 2017-2032 (USD Million)
TABLE 290. India lohexol API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 291. India lohexol API Market Size, by End User, 2017-2032 (USD Million)
TABLE 292. India lohexol API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 293. India lohexol API Market Size, by Application, 2017-2032 (USD Million)
TABLE 294. India lohexol API Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 295. India lohexol API Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 296. Japan lohexol API Market Size, 2017-2032 (USD Million)
TABLE 297. Japan lohexol API Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 298. Japan lohexol API Market Size, by Injection Solution, 2017-2032 (USD Million)
TABLE 299. Japan lohexol API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 300. Japan lohexol API Market Size, by End User, 2017-2032 (USD Million)
TABLE 301. Japan lohexol API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 302. Japan lohexol API Market Size, by Application, 2017-2032 (USD Million)
TABLE 303. Japan lohexol API Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 304. Japan lohexol API Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 305. Australia lohexol API Market Size, 2017-2032 (USD Million)
TABLE 306. Australia lohexol API Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 307. Australia lohexol API Market Size, by Injection Solution, 2017-2032 (USD Million)
TABLE 308. Australia lohexol API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 309. Australia lohexol API Market Size, by End User, 2017-2032 (USD Million)
TABLE 310. Australia lohexol API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 311. Australia lohexol API Market Size, by Application, 2017-2032 (USD Million)
TABLE 312. Australia lohexol API Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 313. Australia lohexol API Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 314. South Korea lohexol API Market Size, 2017-2032 (USD Million)
TABLE 315. South Korea lohexol API Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 316. South Korea lohexol API Market Size, by Injection Solution, 2017-2032 (USD Million)
TABLE 317. South Korea lohexol API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 318. South Korea lohexol API Market Size, by End User, 2017-2032 (USD Million)
TABLE 319. South Korea lohexol API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 320. South Korea lohexol API Market Size, by Application, 2017-2032 (USD Million)
TABLE 321. South Korea lohexol API Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 322. South Korea lohexol API Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 323. Global lohexol API Market Share, by Key Player, 2025
TABLE 324. Global lohexol API Market, Key Experts

Companies Mentioned

  • Alchem International Private Limited
  • Aurora Industry Co., Ltd.
  • Divi’s Laboratories Limited
  • GE HealthCare Technologies Inc.
  • Global Pharma Tek, LLC
  • Hovione Farmaciência SA
  • Imax Diagnostic Imaging Co., Ltd.
  • Interpharma Praha, a.s.
  • Jodas Expoim Private Limited
  • Justesa Imagen, S.A.
  • Lupin Limited
  • Manus Aktteva Biopharma LLP
  • Olon S.p.A.
  • Otsuka Chemical Co., Ltd.
  • Pfizer Inc.
  • Rochem International, Inc.
  • Shaoxing Hantai Pharmaceutical Co., Ltd.
  • Zhejiang Hisun Pharmaceutical Co., Ltd.
  • Zhejiang Neo-Dankong Pharmaceutical Co., Ltd.
  • Zhejiang Starry Pharmaceutical Co., Ltd.

Related Topics

Related Reports

Iodine Contrast Agent API Market - Global Forecast 2026-2032 - Product Image

Iodine Contrast Agent API Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Contrast Media API Market - Global Forecast 2026-2032 - Product Image

Contrast Media API Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
CT and MRI Contrast Agents Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

CT and MRI Contrast Agents Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Contrast Media Market Report by Type, Modality, Application, Route of Administration, End User, and Region 2026-2034 - Product Image

Contrast Media Market Report by Type, Modality, Application, Route of Administration, End User, and Region 2026-2034

  • Report
  • 135 Pages
  • Global
From
Contrast Media Injectors - Global Strategic Business Report - Product Image

Contrast Media Injectors - Global Strategic Business Report

  • Report
  • 467 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.